Tina Smith confronted Mike Lee directly today about his claim that Democrats were behind the shootings.

Elon Musk is pushing AI to the next frontier.
Grok 3.5, the newest version of xAI’s chatbot, rolls into early beta next week—exclusively for SuperGrok users. Unlike typical models, it’s built to reason from first principles, not just regurgitate scraped data.

Musk says it can generate original insights you won’t find anywhere online. If true, this could shift the AI game from data retrieval to true independent reasoning.

A bold claim. A big leap. But is it real innovation—or just more Musk hype?

#Grok3 #ElonMusk #xAI #AInews #ArtificialIntelligence

This inspiring story is about Pamela Gale Malhotra and her husband Anil Malhotra, founders of the Sai Sanctuary Trust in Kodagu (Coorg), Karnataka, India.

In 1991, the couple began purchasing degraded and abandoned farmland with the aim of restoring the native ecosystem.

Over more than two decades, they successfully reforested 300 acres, converting it into a thriving private wildlife sanctuary.

The area, once barren, now hosts:

Over 200 species of wildlife, including elephants, tigers, leopards, and rare birds like the Malabar grey hornbill.

Numerous species of medicinal plants, trees, and native flora.

A healthy rainforest ecosystem with natural water sources restored.

Their work is not just a testament to perseverance but also highlights the importance of rewilding and private conservation efforts in a country facing rapid deforestation and biodiversity loss.

Their sanctuary plays a vital role in maintaining ecological balance in the Western Ghats, one of the world’s biodiversity hotspots.

Japanese researchers, primarily from Kyoto University and the Kitano Hospital, have been developing a novel drug aimed at stimulating natural tooth regeneration.

This research builds upon earlier discoveries related to inhibiting a specific protein called USAG-1 (uterine sensitization-associated gene-1). This protein is known to suppress tooth growth, and by blocking it, the body’s natural pathways for growing new teeth can be reactivated.

The team has already demonstrated success in animal trials — notably in mice and ferrets — where the drug prompted the growth of third-generation teeth, which do not naturally develop in most mammals.

Human trials are reportedly planned to begin around 2025, with hopes of offering this as a treatment for conditions like anodontia (a congenital absence of teeth) or for those who lose teeth due to injury or age.

If successful in humans, this could revolutionize dental care by reducing dependence on implants and dentures, and potentially offering a one-time, regenerative treatment.

However, this "miracle drug" is still under research and not yet available commercially. It must pass through rigorous human clinical trials and safety checks before becoming an approved treatment

〜Gravure〜
Model: A.I.M 恭也



Instagram

#AIM #恭也
#全ての男を過去にする #ホスト #ホストクラブ
#Gravure #AIRGROUP #職業イケメン